Publication | Open Access
Cyclophosphamide, bortezomib and dexamethasone induction for newly diagnosed multiple myeloma: high response rates in a phase II clinical trial
369
Citations
30
References
2009
Year
Hematological MalignancyHealth SciencesMedicineHematologyImmunologyMyeloid NeoplasiaMultiple MyelomaOncologyRadiation OncologyHigh Response RatesDexamethasone Induction
| Year | Citations | |
|---|---|---|
Page 1
Page 1